Filana Therapeutics, Inc. Shares Outstanding (Cover Page)
Filana Therapeutics, Inc. (FLNA) had Shares Outstanding (Cover Page) of 48.31 million shares as of 2026-05-04, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-05-07
- 2026-05-04: Entity Common Stock, Shares Outstanding 48.31M shares.
- 2026-03-09: Entity Common Stock, Shares Outstanding 48.31M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 48.31M shares.
- 2025-08-12: Entity Common Stock, Shares Outstanding 48.31M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-05-04 | 48.31M shares 10-Q · filed 2026-05-07 |
| 2026-03-09 | 48.31M shares 10-K · filed 2026-03-12 |
| 2025-11-10 | 48.31M shares 10-Q · filed 2025-11-12 |
| 2025-08-12 | 48.31M shares 10-Q · filed 2025-08-14 |
| 2025-05-05 | 48.31M shares 10-Q · filed 2025-05-08 |
| 2025-02-27 | 48.31M shares 10-K · filed 2025-03-03 |
| 2024-11-04 | 48.11M shares 10-Q · filed 2024-11-07 |
| 2024-08-05 | 47.98M shares 10-Q · filed 2024-08-08 |
| 2024-05-08 | 47.98M shares 10-Q · filed 2024-05-10 |
| 2024-02-26 | 43.23M shares 10-K · filed 2024-02-28 |
| 2023-11-02 | 42.17M shares 10-Q · filed 2023-11-07 |
| 2023-08-01 | 41.97M shares 10-Q · filed 2023-08-03 |
| 2023-04-27 | 41.75M shares 10-Q · filed 2023-05-01 |
| 2023-02-23 | 41.74M shares 10-K · filed 2023-02-28 |
| 2022-11-04 | 40.07M shares 10-Q · filed 2022-11-07 |
| 2022-08-04 | 40.10M shares 10-Q · filed 2022-08-04 |
| 2022-05-02 | 40.08M shares 10-Q · filed 2022-05-05 |
| 2022-02-24 | 40.02M shares 10-K · filed 2022-03-01 |
| 2021-11-10 | 40.02M shares 10-Q · filed 2021-11-15 |
| 2021-08-02 | 40.01M shares 10-Q · filed 2021-08-04 |
| 2021-04-23 | 40.01M shares 10-Q · filed 2021-04-29 |
| 2021-03-18 | 39.90M shares 10-K · filed 2021-03-23 |
| 2020-11-05 | 25.58M shares 10-Q · filed 2020-11-09 |
| 2020-08-06 | 24.92M shares 10-Q · filed 2020-08-12 |
| 2020-05-01 | 24.78M shares 10-Q · filed 2020-05-06 |
| 2020-03-19 | 24.73M shares 10-K · filed 2020-03-26 |
| 2019-10-24 | 17.22M shares 10-Q · filed 2019-10-29 |
| 2019-08-08 | 17.22M shares 10-Q · filed 2019-08-12 |
| 2019-04-27 | 17.22M shares 10-Q · filed 2019-05-02 |
| 2019-03-22 | 17.22M shares 10-K · filed 2019-03-29 |
| 2018-10-26 | 17.22M shares 10-Q · filed 2018-10-30 |
| 2018-07-24 | 6.98M shares 10-Q · filed 2018-07-26 |
| 2018-04-24 | 6.90M shares 10-Q · filed 2018-05-09 |
| 2018-01-19 | 6.60M shares 10-K · filed 2018-02-06 |
| 2017-10-27 | 6.60M shares 10-Q · filed 2017-11-01 |
| 2017-08-01 | 6.60M shares 10-Q · filed 2017-08-09 |
| 2017-04-24 | 46.14M shares 10-Q · filed 2017-04-26 |
| 2017-01-17 | 46.14M shares 10-K · filed 2017-03-07 |
| 2016-10-19 | 46.14M shares 10-Q · filed 2016-10-26 |
| 2016-07-19 | 46.14M shares 10-Q · filed 2016-07-19 |
| 2016-05-02 | 46.14M shares 10-Q · filed 2016-05-05 |
| 2016-01-12 | 45.76M shares 10-K · filed 2016-03-03 |
| 2015-10-10 | 45.76M shares 10-Q · filed 2015-11-09 |
| 2015-07-10 | 45.76M shares 10-Q · filed 2015-07-23 |
| 2015-04-10 | 45.76M shares 10-Q · filed 2015-05-08 |
| 2015-01-12 | 45.76M shares 10-K · filed 2015-02-18 |
| 2014-10-07 | 45.76M shares 10-Q · filed 2014-11-05 |
| 2014-07-24 | 45.76M shares 10-Q · filed 2014-08-06 |
| 2014-04-10 | 45.61M shares 10-Q · filed 2014-05-07 |
| 2014-01-12 | 45.51M shares 10-K · filed 2014-02-05 |
| 2013-10-10 | 45.44M shares 10-Q · filed 2013-11-01 |
| 2013-07-10 | 45.44M shares 10-Q · filed 2013-08-01 |
| 2013-04-10 | 45.33M shares 10-Q · filed 2013-04-24 |
| 2013-01-31 | 45.33M shares 10-K · filed 2013-02-08 |
| 2012-10-10 | 45.04M shares 10-Q · filed 2012-11-09 |
| 2012-07-10 | 44.79M shares 10-Q · filed 2012-08-02 |
| 2012-04-17 | 44.73M shares 10-Q · filed 2012-05-08 |
| 2012-01-12 | 44.73M shares 10-K · filed 2012-02-09 |
| 2011-10-14 | 44.64M shares 10-Q · filed 2011-11-03 |
| 2011-07-18 | 44.63M shares 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |